1. Home
  2. IDE vs WHWK Comparison

IDE vs WHWK Comparison

Compare IDE & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

IDE

Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

HOLD

Current Price

$13.41

Market Cap

203.7M

Sector

Finance

ML Signal

HOLD

Logo Whitehawk Therapeutics Inc.

WHWK

Whitehawk Therapeutics Inc.

HOLD

Current Price

$3.75

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDE
WHWK
Founded
2010
2007
Country
United States
United States
Employees
N/A
23
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
203.7M
187.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IDE
WHWK
Price
$13.41
$3.75
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.50
AVG Volume (30 Days)
29.1K
641.0K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
8.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.36
$1.57
52 Week High
$14.30
$5.50

Technical Indicators

Market Signals
Indicator
IDE
WHWK
Relative Strength Index (RSI) 42.59 41.30
Support Level $13.27 $3.70
Resistance Level $13.95 $3.79
Average True Range (ATR) 0.24 0.25
MACD -0.02 -0.01
Stochastic Oscillator 39.02 15.79

Price Performance

Historical Comparison
IDE
WHWK

About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.

About WHWK Whitehawk Therapeutics Inc.

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

Share on Social Networks: